Stephen W Fenwick
Overview
Explore the profile of Stephen W Fenwick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Russomanno G, Sison-Young R, Livoti L, Coghlan H, Jenkins R, Kunnen S, et al.
Toxicol Sci
. 2023 Aug;
196(1):112-125.
PMID: 37647630
To minimize the occurrence of unexpected toxicities in early phase preclinical studies of new drugs, it is vital to understand fundamental similarities and differences between preclinical species and humans. Species...
2.
Gilbert T, Hackett J, Holt L, Bird N, Quinn M, Gordon-Weeks A, et al.
Surg Oncol
. 2022 Nov;
45:101875.
PMID: 36384070
Background: Surgery for perihilar cholangiocarcinoma (pCCA) offers the only possibility of long-term survival, but remains a formidable undertaking. Traditionally, 90-day post-operative complications and death are used to define operative risk....
3.
Levy S, Arthur J, Banks M, Kok N, Fenwick S, Diaz-Nieto R, et al.
Ann Surg Oncol
. 2022 Jul;
29(12):7822-7832.
PMID: 35842528
Introduction: Small intestinal neuroendocrine tumors (SI-NETs) often present with metastatic disease. An ongoing debate exists on whether to perform primary tumor resection (PTR) in patients with stage IV SI-NETs, without...
4.
Chan B, Carrion-Alvarez L, Telfer R, Rehman A, Bird N, Mann K, et al.
J Surg Oncol
. 2021 Oct;
125(3):399-404.
PMID: 34689332
Background: Preoperative diagnosis for suspected gallbladder cancers is challenging, with a risk of overtreating benign disease, for example, xanthogranulomatous cholecystitis, with radical cholecystectomies. We retrospectively evaluated the surgeon's intraoperative assessment...
5.
Cuthbertson D, Barriuso J, Lamarca A, Manoharan P, Westwood T, Jaffa M, et al.
Front Endocrinol (Lausanne)
. 2021 Jun;
12:654975.
PMID: 34163434
Objective: Pancreatic neuroendocrine tumours (panNETs) arise sporadically or as part of a genetic predisposition syndrome. CT/MRI, endoscopic ultrasonography and functional imaging using Octreoscan localise and stage disease. This study aimed...
6.
Chan B, Elmasry M, Forootan S, Russomanno G, Bunday T, Zhang F, et al.
Hepatology
. 2021 Apr;
74(2):973-986.
PMID: 33872408
Background And Aims: The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) regulates an array of cytoprotective genes, yet studies in transgenic mice have led to conflicting reports on...
7.
Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones R, et al.
Ann Surg Oncol
. 2020 Sep;
28(3):1493-1498.
PMID: 32914390
Background: Resection margin status is a known prognosticator in patients who undergo resection for hilar cholangiocarcinoma. However, the influence of an isolated positive circumferential margin on clinical outcome is unclear....
8.
Dupre A, Jones R, Diaz-Nieto R, Fenwick S, Poston G, Malik H
World J Surg
. 2019 Jan;
43(5):1351-1359.
PMID: 30673814
Background: Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) have been identified as potential prognostic factors for overall survival (OS) in primary colorectal cancer, and there is a...
9.
Tufo A, Dunne D, Manu N, Lacasia C, Jones L, de Liguori Carino N, et al.
Eur J Surg Oncol
. 2018 Dec;
45(4):635-643.
PMID: 30553630
Background: This study sought to evaluate the impact of the advancements in clinical care, obtained over the last 20 years, for patients aged 70 and older undergoing liver resection for...
10.
Copple I, den Hollander W, Callegaro G, Mutter F, Maggs J, Schofield A, et al.
Arch Toxicol
. 2018 Nov;
93(2):385-399.
PMID: 30426165
The transcription factor NRF2, governed by its repressor KEAP1, protects cells against oxidative stress. There is interest in modelling the NRF2 response to improve the prediction of clinical toxicities such...